(HealthDay)—For ambulatory patients with mild or moderate COVID-19 who are at high risk for progression to severe disease, bamlanivimab plus
Read moreHome »
monoclonal
Scientists find evidence of monoclonal antibodies’ efficacy in fighting malarial infection
Scientists at Walter Reed Army Institute of Research, in a collaboration the Duke University, have confirmed that monoclonal antibodies can
Read more